Árbol del pan para Hiperglucemia (Diabetes)
Artocarpus altilis — 4 estudios científicos revisados
Preliminary¿Sirve Árbol del pan para hiperglucemia (diabetes)?
Se sugiere su uso como terapia complementaria para gestionar complicaciones glucémicas, aunque requiere validación clínica (PMID 39840393).
Compuestos activos involucrados: Alcaloides, Artocarpina, Flavonoides, Quercetina, Terpenos, Fenoles, Glutamato, Polifenoles, Leucina
Evidencia Científica
Los siguientes estudios han investigado la relación entre Árbol del pan y hiperglucemia (diabetes):
Herbal Medicines as Complementary Therapy for Managing Complications in COVID-19 Patients with Diabetes Mellitus.
Diabetes mellitus (DM) is recognized and classified as a group of conditions marked by persistent high blood glucose levels. It is also an inflammatory condition that may influence concurrent disease states, including Coronavirus Disease 2019 (COVID-19). Currently, no effective drug has been found to treat COVID-19, especially in DM patients. Many herbal medicines, such as the well-known Andrographis paniculata, have been explored as drugs and complementary therapies due to their antidiabetic, antibacterial, antiviral, anti-inflammatory, and immunomodulatory effects. This study aimed to examin
PubMed: 39840393Anti-cholinesterase potential of diverse botanical families from Malaysia: Evaluation of crude extracts and fractions from liquid-liquid extraction and acid-base fractionation.
ETHNOPHARMACOLOGICAL RELEVANCE: Enhancement of cholinergic functions in the brain via acetylcholinesterase inhibition is one of the main therapeutic strategies to improve symptoms associated with Alzheimer's or related cognitive deficits. There is a pathophysiological correlation between Alzheimer's and Diabetes Mellitus, as well as inflammation and oxidative stress that may cause cognitive decline. AIM OF THE STUDY: The present study was intended to evaluate anti-cholinesterase potential of 177 Malaysian plant extracts from 148 species known to have related ethnomedicinal uses such as anti-in
PubMed: 31419500Artocarpus altilis (Parkinson) Fosberg Extracts and Geranyl Dihydrochalcone Inhibit STAT3 Activity in Prostate Cancer DU145 Cells.
Artocarpus altilis (Parkinson) Fosberg has traditionally been used in Indonesia for the treatment of liver cirrhosis, hypertension, and diabetes. In many other countries, it is used for the treatment of malaria, yellow fever, and dengue fever. It has been reported that A. altilis extracts have antiatherosclerotic and cytoprotective effects, but its molecular targets in tumor cells are not yet fully understood. The A.
PubMed: 25682949Artocarpus: a review of its traditional uses, phytochemistry and pharmacology.
The genus Artocarpus (Moraceae) comprises about 50 species of evergreen and deciduous trees. Economically, the genus is of appreciable importance as a source of edible fruit, yield fairly good timber and is widely used in folk medicines. The aim of the present review is to present comprehensive information of the chemical constituents, biological and pharmacological research on Artocarpus which will be presented and critically evaluated. The close connection between traditional and modern sources for ethnopharmacological uses of Artocarpus species, especially for treatment against inflammation
PubMed: 20380874Seguridad y Precauciones
La seguridad en el consumo de Artocarpus altilis debe abordarse con cautela, especialmente debido a la presencia de compuestos bioactivos como la artocarpina y diversos flavonoides. En el caso de mujeres embarazadas y en periodo de lactancia, no existe evidencia científica suficiente (PMID 39840393) que garantice la inocuidad de los extractos concentrados o suplementos derivados de la planta sobre el desarrollo fetal o la composición de la leche materna. Debido a su potencial actividad antiinflamatoria y su influencia en procesos metabólicos, se recomienda evitar el uso de extractos terapéuticos durante estas etapas para prevenir cualquier alteración endocrina o inmunológica no estudiada en humanos. Para niños menores de 12 años, el uso de extractos debe ser estrictamente supervisado por un pediatra, ya que la toxicidad potencial en sistemas en desarrollo y la falta de estudios de dosificación pediática limitan su uso seguro como coadyuvante. En cuanto a interacciones farmacológicas, la planta presenta riesgos significativos con fármacos específicos. Debido a sus propiedades reportadas en la gestión de la diabetes (PMID 39840393), existe un riesgo de hipoglucemia si se combina con metformina u otros antidiabéticos, al potenciar el efecto hipoglucemiante.
Otras plantas estudiadas para Hiperglucemia (Diabetes)
Perfil completo: Ver todos los usos y evidencia de Árbol del pan →